Matinas Biopharma Holdings, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
AMEX
Hezbay Holdings LLC has disclosed a beneficial ownership of 9.54% in Matinas BioPharma Holdings Inc. common stock as of July 13, 2026.
AMEX
Highbridge Capital Management, LLC has reported a complete divestment of its beneficial ownership in Matinas BioPharma Holdings, Inc., reducing its stake to 0%.
AMEX
David E. Lazar has disclosed a 9.81% beneficial ownership stake in Matinas BioPharma Holdings, Inc., holding 545,000 shares of common stock.
AMEX
Highbridge Capital Management, LLC has reported an 8.4% beneficial ownership stake in Matinas BioPharma Holdings, Inc., primarily through warrants.